Brief: Exicure will correct some expenses from R&D for quarter ended Sept 30
Dec 1 (Reuters) - Exicure Inc XCUR.O :
* EXICURE-IN PREPARING FINANCIALS FOR QUARTER ENDED SEPT
30,IDENTIFIED IT WAS NOT APPROPRIATE TO RECORD SOME RESEARCH AND
DEVELOPMENT EXPENSES WITH ITS 2023 WIND DOWN ACTIVITIES
* EXICURE INC - ABOUT $0.6 MILLION OF EXPENSES IN Q1 2023
WILL BE
CORRECTED FROM RESEARCH AND DEVELOPMENT INTO GENERAL AND
ADMINISTRATIVE
* EXICURE INC - ABOUT $0.9 MILLION OF EXPENSES IN Q2 2023
WILL BE
CORRECTED FROM RESEARCH AND DEVELOPMENT INTO GENERAL AND
ADMINISTRATIVE
Source text for Eikon: ID:
Further company coverage: XCUR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Exicure
See all newsBrief: Exicure Announces 1-For-5 Reverse Stock Split
U.S. STOCKS ON THE MOVE-MercadoLibre, DoorDash, Coinbase
Brief: Exicure Inc Says Received Nasdaq Delinquency Notice On Late Filing Of Its Form 10-K
Brief: Exicure And Bluejay Therapeutics Enter Into A Patent License Agreement To Develop Cavrotolimod For The Treatment Of Hepatitis
Brief: Exicure Says Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq